The S&P 500 has had a volatile start to 2025 but has still managed to gain 3.8% year to date as of market close on Jan. 24.

The fund has only returned 11% over the last five years, which is poor compared to the broader market. U.S. stocks have been ...

The yield of the S&P 500 is around its lowest level in 25 years, with well-known index funds like the Vanguard S&P 500 ETF ( ...

After enjoying the best back-to-back years since the 1990s, U.S. stock market investors might need to brace for disappointing returns ahead.

Fintel reports that on January 30, 2025, Stifel upgraded their outlook for Edwards Lifesciences (NYSE:EW) from Hold to Buy.

To get a sense of who is truly in control of Recursion Pharmaceuticals, Inc. ( NASDAQ:RXRX ), it is important to understand the ownership structure of the business. With 66% stake, institutions ...

XEQT, a triple threat ETF with low fees, diversified holdings, and strong performance for Canadian investors seeking global ...

"We talk about the S-curve for technology and in the past we've said it can be 10 or 20 years before you reach the top. I think what's going to be really different about AI is that time frame is going ...

Here are two tips and tricks to get the most out of your TFSA.

This top ETF offering could be a great buy with an extra $2,000.

The DVY ETF offers market-cap-weighted exposure to U.S. companies with a consistent history of paying dividends. It has 90 ...

Welcome to Marsh McLennan's Earnings Conference Call. Today's call is being recorded. Fourth quarter 2024 financial results and supplemental information were issued earlier this morning. They are ...